Clinical Trials Browser

Completed × INDUSTRY × brexucabtagene autoleucel × Clear all

NCT02625480 2026-04-09

ZUMA-4

Phase 1/2 Completed

Recurrence, Lymphoma, B-Cell

NCT02601313 2026-03-18

ZUMA-2

Phase 2 Completed

105 enrolled 33 charts 1 FDA

Lymphoma, Mantle-Cell

NCT04880434 2025-11-17

ZUMA-2

Phase 2 Completed

Lymphoma, Mantle-Cell

NCT02614066 2024-11-19

ZUMA-3

Phase 1/2 Completed

125 enrolled 27 charts 1 FDA

Recurrence